Muller Lorenz — SEC Form 4 filings
SEC reporting owner CIK 1771207. 6 Form 4 filings on record with FilingPulse; latest filed 2026-02-05.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2025-01-29 to 2026-02-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 64,746 shares, $145,851 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 53,566 shares @ $2.32 ($124,273) in Milestone Pharmaceuticals Inc., filed 2026-01-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | Chief Commercial Officer | 6 | — | 2 legs · 64,746 sh · $145,851 | 13 |
Form 4 filings — Muller Lorenz
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-05 | 4/A | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 204,000 (derivative) @ $0 | EDGAR |
| 2026-02-04 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 204,000 (derivative) @ $0 · Grant/award (A): 136,000 (derivative) @ $0 | EDGAR |
| 2026-01-28 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 100,000 · Sale (S): 53,566 @ $2.32 · Option exercise (M): 20,100 · Sale (S): 11,180 @ $1.93 · Grant/award (A): 100,000 (derivative) @ $0 · Option exercise (M): 20,100 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Gift (G): 25,000 @ $0 | EDGAR |
| 2025-07-15 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 66,666 · Grant/award (A): 66,666 (derivative) · Grant/award (A): 66,666 (derivative) | EDGAR |
| 2025-01-29 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 120,600 (derivative) @ $0 · Grant/award (A): 80,400 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1771207 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →